T1	Outcomes 1289 1347	weeks, American College of Rheumatology 20/50/70 responses
T2	Outcomes 1458 1462	91).
T3	Outcomes 1463 1521	European League Against Rheumatism good/moderate responses
T4	Outcomes 1577 1581	90).
T5	Outcomes 1582 1638	Rates of adverse events (AE), serious AE, and infections
T6	Outcomes 1658 1665	stable.
T7	Outcomes 1666 1698	Rate of progressive joint damage
T8	Outcomes 1820 1827	groups.
T9	Outcomes 1828 1860	Mean change from baseline in PJD
